Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer

Medical Science Monitor ◽

10.12659/msm.918620 ◽

2019 ◽

Vol 25 ◽

pp. 9280-9289 ◽

Cited By ~ 2

Author(s):

Xingyuan Liu ◽

Xuefeng Liu ◽

Jingyuan Li ◽

Fu Ren

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Integrated Analysis ◽

Small Cell Lung ◽

Diagnosis And Prognosis

Download Full-text

Entrectinib in neurotrophic receptor tyrosine kinase fusion-positive (NTRK- fp) non-small cell lung cancer (NSCLC): integrated analysis of patients enrolled in STARTRK-2, STARTRK-1 and ALKA-372-001

10.1055/s-0039-3403355 ◽

2020 ◽

Author(s):

L Paz-Ares ◽

RC Doebel ◽

AF Farago ◽

S Liu ◽

SP Chawla ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Receptor Tyrosine Kinase ◽

Small Cell ◽

Integrated Analysis ◽

Small Cell Lung

Download Full-text

Prognostic value of Lung Cancer Subscale in older patients with advanced non-small cell lung cancer: An integrated analysis of JCOG0207 and JCOG0803/WJOG4307L (JCOG1414A)

Journal of Geriatric Oncology ◽

10.1016/j.jgo.2018.04.005 ◽

2018 ◽

Vol 9 (6) ◽

pp. 583-588 ◽

Cited By ~ 1

Author(s):

Tomonori Mizutani ◽

Masahiko Ando ◽

Junki Mizusawa ◽

Kenichi Nakamura ◽

Haruhiko Fukuda ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Older Patients ◽

Prognostic Value ◽

Small Cell ◽

Integrated Analysis ◽

Small Cell Lung

Download Full-text

Integrated analysis of the prognostic value of TP53 dependent etoposide-induced gene 24 in non-small cell lung cancer

Biomedicine & Pharmacotherapy ◽

10.1016/j.biopha.2019.01.051 ◽

2019 ◽

Vol 112 ◽

pp. 108590

Author(s):

Maofeng Wang ◽

Peipei Li ◽

Rugen Wan ◽

Xiyong Liu

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Prognostic Value ◽

Small Cell ◽

Integrated Analysis ◽

Small Cell Lung

Download Full-text

Tumor markers (CEA, CA 125, CYFRA 21.1, SCC and NSE) in non small cell lung cancer (NSCLC) patients as an aid in histological diagnosis and prognosis: Comparison with the main clinical and pathological prognostic factors

Lung Cancer ◽

10.1016/s0169-5002(00)80662-5 ◽

2000 ◽

Vol 29 (1) ◽

pp. 195

Author(s):

N Vinolas ◽

R Molina ◽

R Fuentes ◽

I Bover ◽

J Rifa ◽

...

Keyword(s):

Lung Cancer ◽

Prognostic Factors ◽

Small Cell Lung Cancer ◽

Tumor Markers ◽

Cell Lung Cancer ◽

Small Cell ◽

Ca 125 ◽

Small Cell Lung ◽

Diagnosis And Prognosis ◽

Nsclc Patients

Download Full-text

Serum Cripto-1 is a novel biomarker for non-small cell lung cancer diagnosis and prognosis

The Clinical Respiratory Journal ◽

10.1111/crj.12414 ◽

2016 ◽

Vol 11 (6) ◽

pp. 765-771 ◽

Cited By ~ 14

Author(s):

Chun Hua Xu ◽

Yan Wang ◽

Li Hua Qian ◽

Li Ke Yu ◽

Xiu Wei Zhang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Diagnosis ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Diagnosis And Prognosis ◽

Lung Cancer Diagnosis ◽

Cancer Diagnosis And Prognosis

Download Full-text

Entrectinib in locally advanced/metastatic ROS1 and NTRK fusion-positive non-small cell lung cancer (NSCLC): Updated integrated analysis of STARTRK-2, STARTRK-1 and ALKA-372-001

Annals of Oncology ◽

10.1093/annonc/mdz420.003 ◽

2019 ◽

Vol 30 ◽

pp. ix24-ix25

Author(s):

F. de Braud ◽

S. Siena ◽

F. Barlesi ◽

A. Drilon ◽

B. Simmons ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Locally Advanced ◽

Small Cell ◽

Integrated Analysis ◽

Small Cell Lung

Download Full-text

Serum tumour M2‐pyruvate kinase as a biomarker for diagnosis and prognosis of early‐stage non–small cell lung cancer

Journal of Cellular and Molecular Medicine ◽

10.1111/jcmm.16762 ◽

2021 ◽

Author(s):

Chunhua Xu ◽

Wei Liu ◽

Li Li ◽

Yuchao Wang ◽

Qi Yuan

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Pyruvate Kinase ◽

Cell Lung Cancer ◽

Early Stage ◽

Small Cell ◽

Small Cell Lung ◽

Diagnosis And Prognosis ◽

Serum Tumour

Download Full-text

Circulating tumor cells in pulmonary vein and peripheral arterial provide a metric for PD-L1 diagnosis and prognosis of patients with non-small cell lung cancer

PLoS ONE ◽

10.1371/journal.pone.0220306 ◽

2019 ◽

Vol 14 (7) ◽

pp. e0220306 ◽

Cited By ~ 1

Author(s):

Jingsi Dong ◽

Daxing Zhu ◽

Xiaojun Tang ◽

Dan Lu ◽

Xiaoming Qiu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Tumor Cells ◽

Pulmonary Vein ◽

Circulating Tumor Cells ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Diagnosis And Prognosis ◽

Peripheral Arterial

Download Full-text

Integrated analysis of differential expression and alternative splicing of non-small cell lung cancer based on RNA sequencing

Oncology Letters ◽

10.3892/ol.2017.6300 ◽

2017 ◽

Vol 14 (2) ◽

pp. 1519-1525 ◽

Cited By ~ 3

Author(s):

Zulei Li ◽

Kai Zhao ◽

Hui Tian

Keyword(s):

Lung Cancer ◽

Alternative Splicing ◽

Small Cell Lung Cancer ◽

Differential Expression ◽

Rna Sequencing ◽

Cell Lung Cancer ◽

Small Cell ◽

Integrated Analysis ◽

Small Cell Lung

Download Full-text

Tumor Markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in Patients with Non-Small Cell Lung Cancer as an Aid in Histological Diagnosis and Prognosis

Tumor Biology ◽

10.1159/000074432 ◽

2003 ◽

Vol 24 (4) ◽

pp. 209-218 ◽

Cited By ~ 148

Author(s):

R. Molina ◽

X. Filella ◽

J.M. Augé ◽

R. Fuentes ◽

I. Bover ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Tumor Markers ◽

Cell Lung Cancer ◽

Small Cell ◽

Histological Diagnosis ◽

Ca 125 ◽

Small Cell Lung ◽

Diagnosis And Prognosis

Download Full-text

Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer

Entrectinib in neurotrophic receptor tyrosine kinase fusion-positive (NTRK- fp) non-small cell lung cancer (NSCLC): integrated analysis of patients enrolled in STARTRK-2, STARTRK-1 and ALKA-372-001

Prognostic value ​of Lung Cancer Subscale in older patients with advanced non-small cell lung cancer: An integrated analysis of JCOG0207 and JCOG0803/WJOG4307L (JCOG1414A)

Integrated analysis of the prognostic value of TP53 dependent etoposide-induced gene 24 in non-small cell lung cancer

Tumor markers (CEA, CA 125, CYFRA 21.1, SCC and NSE) in non small cell lung cancer (NSCLC) patients as an aid in histological diagnosis and prognosis: Comparison with the main clinical and pathological prognostic factors

Serum Cripto-1 is a novel biomarker for non-small cell lung cancer diagnosis and prognosis

Entrectinib in locally advanced/metastatic ROS1 and NTRK fusion-positive non-small cell lung cancer (NSCLC): Updated integrated analysis of STARTRK-2, STARTRK-1 and ALKA-372-001

Serum tumour M2‐pyruvate kinase as a biomarker for diagnosis and prognosis of early‐stage non–small cell lung cancer

Circulating tumor cells in pulmonary vein and peripheral arterial provide a metric for PD-L1 diagnosis and prognosis of patients with non-small cell lung cancer

Integrated analysis of differential expression and alternative splicing of non-small cell lung cancer based on RNA sequencing

Tumor Markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in Patients with Non-Small Cell Lung Cancer as an Aid in Histological Diagnosis and Prognosis

Prognostic value of Lung Cancer Subscale in older patients with advanced non-small cell lung cancer: An integrated analysis of JCOG0207 and JCOG0803/WJOG4307L (JCOG1414A)